Please login to the form below

Not currently logged in
Email:
Password:

ClinTec appoints regional manager for Spain and Portugal

Carlos Palacios joins the contract research organisation

Contract research organisation ClinTec International has appointed Carlos Palacios to the newly-created position of regional manager for Spain and Portugal.

The appointment comes as the UK-headquartered clinical service provider expands its Spanish business, moving to a larger office in Barcelona and opening a new location in Madrid.

Palacios joins ClinTec from Merck, where he served as its clinical account manager and site relationship and operations lead, overseeing global trials across Spain, Portugal, Israel and the Netherlands.

He brings over 16 years of experience in the clinical research industry at local and global levels to the organisation, having previously held management roles at Chiltern International, drug Solutions and Merck & Co.

Dr Rabinder Buttar, founder and chief executive officer of ClinTec, said: “The creation of the new regional management post and the opening of the two new offices in Madrid and Barcelona signal that ClinTec is developing and expanding in line with our current client's needs and that as a company we are ready to take on new business of all sizes.

“I am delighted Carlos has joined our team at ClinTec as we continue to expand our business in the Spanish and Portuguese region.”

31st May 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...